Leveraging the mature technology system of the human IVD industry, with "technology downgrade innovation + compliant ecosystem building" at its core, we deliver an integrated precision diagnostic solution of instruments, consumables, data services, and expert ecosystem for pet healthcare.
Anhui Chongyi Biotechnology Co., Ltd. is a biotechnology company focused on veterinary diagnostics, committed to the standardization and normalization of pet healthcare.
R&D + Manufacturing + Operations
Anhui Chongyi Biotechnology Co., Ltd. ("Chongyi Bio") is a biotechnology company focused on veterinary diagnostics, with its core competitiveness in "technology downgrade innovation + compliant ecosystem building."
Drawing on the technical know-how and resources of the human IVD (In-Vitro Diagnostics) industry, the company specializes in R&D, manufacturing, sales, and technical services of veterinary diagnostic products, delivering an integrated "instrument + consumable + data service + expert ecosystem" solution for the pet healthcare industry.
Our strategic goal: to advance the standardization and normalization of pet healthcare and become a pioneer in setting standards for veterinary laboratory medicine.
Precision veterinary diagnostics, empowering clinical practice, protecting companion lives
To be the preferred enabler and partner in global pet health
From standardized production facilities to real pet clinical scenarios, building a complete closed loop from R&D to diagnostics.
Six platform-based product lines covering immunoassay, biochemistry, molecular imaging, oncology, regenerative medicine, and smart LIS—building a complete closed-loop from screening to treatment.
An immunoprotein analysis platform built for veterinary care, covering outpatient rapid testing to high-throughput central lab scenarios.

Desktop fully automated immunoprotein analyzer; up to 15 tests simultaneously, 12-minute reports.
Learn More →
Benchtop compact analyzer; up to 30 tests simultaneously, for mid-size hospitals and regional labs.
Learn More →
Flagship high-throughput analyzer; up to 50 tests simultaneously, for core labs and large hospital chains.
Learn More →Covers chemiluminescence, hematology, body fluid, and blood-gas analysis to meet full clinical diagnostic needs.

Chemiluminescence immunoassay analyzer — sensitive quantitative testing of hormones, infectious and inflammatory markers.
Learn More →
5-part differential automated animal hematology analyzer — sheath-flow + multi-angle laser scattering, for dogs, cats and more.
Learn More →
Blood-gas & electrolyte analyzer — bedside rapid testing of pH, blood gas, electrolytes and lactate.
Learn More →
Body-fluid analyzer — routine and biochemical analysis of pleural, peritoneal, CSF and joint fluids.
Learn More →Combines advanced medical imaging, AI pathology, flow cytometry, and molecular diagnostics for precise classification and lesion localization.

100% helium-free superconducting MRI — zero-helium care, smart algorithms and HD imaging for whole-body pet diagnostics.
Learn More →
Flow-cytometry platform — lymphocyte subset and immune-status assessment via CD4 / CD8 / CD19.
Learn More →
Molecular (nucleic-acid) diagnostics — PCR-based high-sensitivity pathogen and genetic testing.
Learn More →From tumor screening and AI smart diagnosis to precision radiotherapy and post-operative care, building full-lifecycle tumor management.

High-precision tumor radiotherapy — image-guided, conformal/IMRT delivery that spares normal tissue.
Learn More →
Independent ICU space with integrated oxygen, heating and humidification to reduce stress and cross-infection.
Learn More →
Pet pathology center: HE staining, IHC, cytology and flow cytometry, with expert review and traceable slides.
Learn More →
5-item pet tumor-marker early screening with dog/cat-specific reference ranges; combined testing improves detection.
Learn More →Introduces regenerative medicine and cell therapy technologies to provide breakthrough treatment options for veterinary care.

Absorbable flexible 3D scaffold — in-situ forming, naturally resorbed, for tissue repair, cavity filling and active-agent delivery.
Learn More →
Peptide-glycan complex (Memactin) for repair and regeneration of soft tissue, bone-joint and corneal injuries in dogs and cats.
Learn More →
CAR-T cell therapy — personalized cellular immunotherapy for relapsed/refractory pet tumors.
Learn More →Integrating the AI-LIS smart laboratory system with multi-level quality control materials, connecting instruments, data, and quality management for accurate, traceable results.

AI-LIS smart laboratory system — end-to-end informatization linking instruments, data and quality control.
Learn More →
Multi-level quality-control materials spanning biochemistry, immunoassay, CBC and more.
Learn More →12 pending patents and 4 filed patents build a complete technical barrier.
Core blood-cell counting tech based on a lab-on-chip prototype, capturing cell electrical properties via microchannels and impedance sensing.
High-sensitivity immunoassay using special substrates and signal amplification to lower detection limits.
Intelligent pathology aid using deep-learning models for feature extraction and pattern recognition across species.
Breakthrough molecular diagnostics amplifying and reading nucleic acids at constant temperature, no PCR thermal cycling.
From precise identification of high-risk individuals to empathetic communication and rigorous execution—building a standardized screening loop.
For senior dogs/cats over 8 and high-incidence breeds, proactively detect subclinical lesions via annual check-ups.
When imaging finds a space-occupying lesion, provide key lab evidence to support a more precise plan.
Continuously monitor marker trends to objectively evaluate surgery or chemo efficacy in real time.
The most sensitive post-op follow-up indicator—detecting minimal residual or metastasis earlier than imaging.
The founding team has 15 years of experience in R&D, manufacturing, and quality control of IVD products, applying mature human IVD technologies to pet healthcare.

North Dakota State University · Molecular Biology

Hefei University of Technology · Analytical Chemistry

China Agricultural University · Veterinary Medicine
15 years of IVD localization experience
Helping front-line practitioners master the full workflow of tumor screening—from precise identification to professional communication.
Define high-risk breeds, critical ages, and abnormal signs to build a scientific basis for intervention.
Master techniques to explain screening value in plain language and improve owner compliance.
Establish a standardized post-positive workflow combining imaging and lab tests.
Learn reassuring, professional phrasing to reduce owner anxiety and protect trust.
As a pioneer in industry standards, we look forward to partnering with global collaborators to protect companion-animal health.